If you liked this article you might like

Johnson & Johnson Is Setting Up for a Rally
Jim Cramer's 'Mad Money' Recap: Tune Out the Fed, Focus on What Matters
EpiPen Controversy: Mylan's Tough Week Just Keeps Getting Grimmer
Johnson & Johnson Sees Growth in Ophthalmology, Acquires Abbott Medical Optics